339 related articles for article (PubMed ID: 26228671)
1. Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a).
Krychtiuk KA; Kastl SP; Hofbauer SL; Wonnerth A; Goliasch G; Ozsvar-Kozma M; Katsaros KM; Maurer G; Huber K; Dostal E; Binder CJ; Pfaffenberger S; Oravec S; Wojta J; Speidl WS
J Clin Lipidol; 2015; 9(4):533-41. PubMed ID: 26228671
[TBL] [Abstract][Full Text] [Related]
2. Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease.
Czepluch FS; Kuschicke H; Dellas C; Riggert J; Hasenfuss G; Schäfer K
J Intern Med; 2014 Feb; 275(2):144-54. PubMed ID: 24118494
[TBL] [Abstract][Full Text] [Related]
3. Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease.
Krychtiuk KA; Kastl SP; Pfaffenberger S; Lenz M; Hofbauer SL; Wonnerth A; Koller L; Katsaros KM; Pongratz T; Goliasch G; Niessner A; Gaspar L; Huber K; Maurer G; Dostal E; Wojta J; Oravec S; Speidl WS
PLoS One; 2015; 10(4):e0123367. PubMed ID: 25849089
[TBL] [Abstract][Full Text] [Related]
4. Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease.
Krychtiuk KA; Kastl SP; Pfaffenberger S; Pongratz T; Hofbauer SL; Wonnerth A; Katsaros KM; Goliasch G; Gaspar L; Huber K; Maurer G; Dostal E; Oravec S; Wojta J; Speidl WS
Atherosclerosis; 2014 Dec; 237(2):589-96. PubMed ID: 25463093
[TBL] [Abstract][Full Text] [Related]
5. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
[TBL] [Abstract][Full Text] [Related]
6. The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization.
Fefer P; Tsimikas S; Segev A; Sparkes J; Otsuka F; Kolodgie F; Virmani R; Juliano J; Charron T; Strauss BH
Cardiovasc Revasc Med; 2012; 13(1):11-9. PubMed ID: 22079685
[TBL] [Abstract][Full Text] [Related]
7. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
Rogacev KS; Cremers B; Zawada AM; Seiler S; Binder N; Ege P; Große-Dunker G; Heisel I; Hornof F; Jeken J; Rebling NM; Ulrich C; Scheller B; Böhm M; Fliser D; Heine GH
J Am Coll Cardiol; 2012 Oct; 60(16):1512-20. PubMed ID: 22999728
[TBL] [Abstract][Full Text] [Related]
8. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
Lapuc I; Bolkun L; Eljaszewicz A; Rusak M; Luksza E; Singh P; Miklasz P; Piszcz J; Ptaszynska-Kopczynska K; Jasiewicz M; Kaminski K; Dabrowska M; Bodzenta-Lukaszyk A; Kloczko J; Moniuszko M
Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
[TBL] [Abstract][Full Text] [Related]
9. The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles.
Arai K; Luke MM; Koschinsky ML; Miller ER; Pullinger CR; Witztum JL; Kane JP; Tsimikas S
Atherosclerosis; 2010 Apr; 209(2):498-503. PubMed ID: 19880117
[TBL] [Abstract][Full Text] [Related]
10. Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry.
Thomas GD; Hamers AAJ; Nakao C; Marcovecchio P; Taylor AM; McSkimming C; Nguyen AT; McNamara CA; Hedrick CC
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1548-1558. PubMed ID: 28596372
[TBL] [Abstract][Full Text] [Related]
11. Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease.
Nsaibia MJ; Mahmut A; Boulanger MC; Arsenault BJ; Bouchareb R; Simard S; Witztum JL; Clavel MA; Pibarot P; Bossé Y; Tsimikas S; Mathieu P
J Intern Med; 2016 Nov; 280(5):509-517. PubMed ID: 27237700
[TBL] [Abstract][Full Text] [Related]
12. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
[TBL] [Abstract][Full Text] [Related]
13. Monocyte heterogeneity in myocardial infarction with and without ST elevation and its association with angiographic findings.
Arslan U; Kocaoğlu I; Balci MM; Gülkan B; Falay MY; Temizhan A
Coron Artery Dis; 2013 Aug; 24(5):404-11. PubMed ID: 23612365
[TBL] [Abstract][Full Text] [Related]
14. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG;
Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of Toll-like receptor 4 and human monocyte subsets in acute myocardial infarction.
Kashiwagi M; Imanishi T; Ozaki Y; Satogami K; Masuno T; Wada T; Nakatani Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Akasaka T
Atherosclerosis; 2012 Mar; 221(1):249-53. PubMed ID: 22244044
[TBL] [Abstract][Full Text] [Related]
16. Association of Toll-Like Receptor 4 on Human Monocyte Subsets and Vulnerability Characteristics of Coronary Plaque as Assessed by 64-Slice Multidetector Computed Tomography.
Ozaki Y; Imanishi T; Hosokawa S; Nishiguchi T; Taruya A; Tanimoto T; Kuroi A; Yamano T; Matsuo Y; Ino Y; Kitabata H; Kubo T; Tanaka A; Akasaka T
Circ J; 2017 May; 81(6):837-845. PubMed ID: 28344199
[TBL] [Abstract][Full Text] [Related]
17. Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a).
Yeang C; Hung MY; Byun YS; Clopton P; Yang X; Witztum JL; Tsimikas S
J Clin Lipidol; 2016; 10(3):594-603. PubMed ID: 27206947
[TBL] [Abstract][Full Text] [Related]
18. Circulating CD14+CD16+ monocyte subsets as biomarkers of the severity of coronary artery disease in patients with stable angina pectoris.
Ozaki Y; Imanishi T; Taruya A; Aoki H; Masuno T; Shiono Y; Komukai K; Tanimoto T; Kitabata H; Akasaka T
Circ J; 2012; 76(10):2412-8. PubMed ID: 22785372
[TBL] [Abstract][Full Text] [Related]
19. Correlation Between High-Density Lipoprotein and Monocyte Subsets in Patients with Stable Coronary Heart Disease.
Jiang S; Li D; Li J; An Y
Med Sci Monit; 2015 Jun; 21():3129-35. PubMed ID: 26474031
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
